| 注册
首页|期刊导航|同位素|125I粒子组织间植入近距离治疗恶性肿瘤

125I粒子组织间植入近距离治疗恶性肿瘤

胡疏 成先义 高宙 尹为华 孙德胜 陈俊辉 贾少微

同位素2011,Vol.24Issue(1):34-38,5.
同位素2011,Vol.24Issue(1):34-38,5.

125I粒子组织间植入近距离治疗恶性肿瘤

Investigation on Curative Efficacy for Malignant Tumor by Implantation 125Ⅰ Permanent Brachytherapy Seeds

胡疏 1成先义 2高宙 1尹为华 3孙德胜 4陈俊辉 2贾少微1

作者信息

  • 1. 北京大学深圳医院核医学科,广东深圳,518036
  • 2. 北京大学深圳医院微创介入科,广东深圳,518036
  • 3. 北京大学深圳医院病理科,广东深圳,518036
  • 4. 北京大学深圳医院超声影像科,广东深圳,518036
  • 折叠

摘要

Abstract

Twenty inpatients suffered from malignant tumors with twenty-four lesions were treated with 125Ⅰ permanent brachytherapy seed in Peking University Shenzhen Hospital, and the feasibility, curative effect and adverse effect of the treatment were observed. Before 125I seeds implantation, the three-dimensional treatment planning was preconcerted. There were two methods to implant 125Ⅰ seeds. One was to insert the seeds in the location of residual focus and metastatic lesions of the tumors directly in ordinary operations or through laparoscopy under general anesthesia. The other was to implant the seeds into the tumors through percutaneous needles by the guidance of CT scanning or color doppler ultrasonography under local anesthesia. The implantations for all of the 20 patients (24 lesions) were performed successfully. During and one week after the implantation, the distributions of the planted seeds were approximately the same as the scheduled three-dimensional treatment planning, and no seed migration was found. Adverse reactions during and after the operation were slight and recovered after correlative treatments. Clinical symptoms were palliated and serum tumor marker decreased to a different extent among most patients. The complete remission (CR) rate is 20.00% ( 4/20 patients ),the partial remission(PR) rate is 35.00%( 7/20 patients),the stable disease (SD) rate is 30.00 % ( 6/20 patients ), the progressive disease (PD) rate is 15.00% (3/20 patients), and the overall response rate (CR+PR) is 53.33% ( 8 patients). 125Ⅰ seeds implantation for targeted therapy is convenient, safe and effective on malignant tumor, and is well worth advanced application.

关键词

125I粒子/近距离放射疗法/恶性肿瘤

Key words

125Ⅰ seeds/ brachytherapy/ malignant tumor

分类

医药卫生

引用本文复制引用

胡疏,成先义,高宙,尹为华,孙德胜,陈俊辉,贾少微..125I粒子组织间植入近距离治疗恶性肿瘤[J].同位素,2011,24(1):34-38,5.

基金项目

卫生部科技发展中心"瘤内免疫靶向放疗联合微波消融技术治疗肺癌的临床研究"资助项目(W2009BX045) (W2009BX045)

同位素

OACSTPCD

1000-7512

访问量0
|
下载量0
段落导航相关论文